Evidence-Based Strategies for Micro-elimination of Chronic Hepatitis B Virus Infection
Open Access
- 29 July 2023
- journal article
- research article
- Published by Springer Nature in Current Hepatology Reports
- Vol. 22 (3) , 118-129
Abstract
Purpose of Review: Hepatitis B (HBV) remains a health threat around the world. Hepatitis C is closer to meeting the World Health Organization’s 2030 elimination goal compared to HBV. To achieve a successful micro-elimination and macro-elimination, there are certain objectives that need to be met. Recent Findings: HBV infects more than 262 million people worldwide and is associated with significant morbidity and increased mortality. There have been previous HBV and hepatitis C virus micro-elimination trials with varying success. Micro-elimination programs should be designed to move services forward with a plethora of avenues for monitoring, testing, and treatment. Summary: Ultimately, successful and maintained micro-elimination is needed to achieve macro-elimination of HBV. Here, we propose 5 core tenets of micro-elimination that can be expanded to macro-elimination; these 5-line guidelines provide for 5 pillars of HBV management that support a path to a successful global elimination of HBV.Keywords
This publication has 91 references indexed in Scilit:
- Neuropsychiatric and Psychosocial Issues of Patients With Hepatitis C Infection: A Selective Literature ReviewHepatitis Monthly, 2013
- Recent trends in hepatitis B virus infection in the general Korean populationThe Korean Journal of Internal Medicine, 2013
- San Francisco Hep B Free: A Grassroots Community Coalition to Prevent Hepatitis B and Liver CancerJournal of Community Health, 2010
- Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusionTransfusion, 2009
- Transient occult hepatitis B virus infection in a blood donor with high viremiaTransfusion, 2009
- Hepatitis B: The virus and disease #Hepatology, 2009
- Health‐related stigmaSociology of Health & Illness, 2009
- Stigma in the HIV/AIDS epidemic: a review of the literature and recommendations for the way forwardAIDS, 2008
- Tenofovir (TDF) has stronger antiviral effect than adefovir (ADV) against lamivudine (LAM)-resistant hepatitis B virus (HBV)Hepatology International, 2008
- A COMPREHENSIVE PROGRAMME TO REDUCE THE INCIDENCE OF HEPATITIS B VIRUS INFECTION AND ITS SEQUELAE IN ALASKAN NATIVESThe Lancet, 1987